TABLE OF CONTENTS
| | | | Volume 36, Issue 21 (May 2017) | | In this issue Original Articles Short Communication
Also new AOP | | | | Original Articles | Top | | Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas OPENC Tonelli, M J Morelli, A Sabò, A Verrecchia, L Rotta, T Capra, S Bianchi, S Campaner and B Amati Oncogene 2017 36: 2921-2929; advance online publication, January 16, 2017; 10.1038/onc.2016.443 Abstract | Full Text | | | | EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis OPENS-A Wang, Y-C Wang, Y-P Chuang, Y-H Huang, W-C Su, W-C Chang and J-J Hung Oncogene 2017 36: 2930-2945; advance online publication, December 19, 2016; 10.1038/onc.2016.445 Abstract | Full Text | | | | A targetable HB-EGF–CITED4 axis controls oncogenesis in lung cancerC-H Hsieh, Y-T Chou, M-H Kuo, H-P Tsai, J-L Chang and C-W Wu Oncogene 2017 36: 2946-2956; advance online publication, January 16, 2017; 10.1038/onc.2016.465 Abstract | Full Text | | | | Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinomaH Sun, Z Peng, H Tang, D Xie, Z Jia, L Zhong, S Zhao, Z Ma, Y Gao, L Zeng, R Luo and K Xie Oncogene 2017 36: 2957-2968; advance online publication, February 13, 2017; 10.1038/onc.2016.447 Abstract | Full Text | | | | IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancerQ Yang, X Li, H Chen, Y Cao, Q Xiao, Y He, J Wei and J Zhou Oncogene 2017 36: 2969-2980; advance online publication, January 16, 2017; 10.1038/onc.2016.448 Abstract | Full Text | | | | Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survivalC Kerr, H Szmacinski, M L Fisher, B Nance, J R Lakowicz, A Akbar, J W Keillor, T Lok Wong, R Godoy-Ruiz, E A Toth, D J Weber and R L Eckert Oncogene 2017 36: 2981-2990; advance online publication, December 12, 2016; 10.1038/onc.2016.452 Abstract | Full Text | | | | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formationJ Li, Y Xi, W Li, R L McCarthy, S A Stratton, W Zou, W Li, S Y Dent, A K Jain and M C Barton Oncogene 2017 36: 2991-3001; advance online publication, January 9, 2017; 10.1038/onc.2016.453 Abstract | Full Text | | | | The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination OPENE Crosas-Molist, E Bertran, I Rodriguez-Hernandez, C Herraiz, G Cantelli, À Fabra, V Sanz-Moreno and I Fabregat Oncogene 2017 36: 3002-3014; advance online publication, December 12, 2016; 10.1038/onc.2016.454 Abstract | Full Text | | | | PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancerD A Modi, R D Tagare, S Karthikeyan, A Russo, M Dean, D A Davis, D D Lantvit and J E Burdette Oncogene 2017 36: 3015-3024; advance online publication, December 19, 2016; 10.1038/onc.2016.455 Abstract | Full Text | | | | Emergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinomaH Gurler Main, J Xie, G G Muralidhar, O Elfituri, H Xu, A A Kajdacsy-Balla and M V Barbolina Oncogene 2017 36: 3025-3036; advance online publication, December 12, 2016; 10.1038/onc.2016.456 Abstract | Full Text | | | | Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeuticF Volpin, J Casaos, J Sesen, A Mangraviti, J Choi, N Gorelick, J Frikeche, T Lott, R Felder, S J Scotland, T S K Eisinger-Mathason, H Brem, B Tyler and N Skuli Oncogene 2017 36: 3037-3047; advance online publication, December 12, 2016; 10.1038/onc.2016.457 Abstract | Full Text | | | | Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma OPENX Wang, M Lang, T Zhao, X Feng, C Zheng, C Huang, J Hao, J Dong, L Luo, X Li, C Lan, W Yu, M Yu, S Yang and H Ren Oncogene 2017 36: 3048-3058; advance online publication, December 19, 2016; 10.1038/onc.2016.458 Abstract | Full Text | | Short Communication | Top | | Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinomaA Miller, L McLeod, S Alhayyani, A Szczepny, D N Watkins, W Chen, P Enriori, W Ferlin, S Ruwanpura and B J Jenkins Oncogene 2017 36: 3059-3066; advance online publication, November 28, 2016; 10.1038/onc.2016.437 Abstract | Full Text | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | |
No comments:
Post a Comment